Alt text: Tall brown brick Art Deco skyscraper under clear sky with adjacent modern glass building.

Our Wins

  • Montana $97,032.00

    Arteriosclerotic heart disease with congestive heart failure granted at 100%, sleep apnea at 50%, chronic sinusitis at 30%, and multiple additional conditions service-connected, with housebound SMC and Dependents’ Educational Assistance eligibility, effective 2024.

  • Mississippi $228,300.58

    PTSD with major depressive disorder, OCD, alcohol use disorder, and binge eating disorder granted at 100%, with housebound SMC and Dependents’ Educational Assistance eligibility, effective 2018.

  • Virginia $96,090.06

    Service connection granted for multiple left and right knee strain conditions, meniscal tear, chondromalacia, and instability with updated evaluations through 2026.

  • Virginia $98,523.12

    Bipolar disorder increased from 50% to 100% with eligibility for Dependents’ Educational Assistance, effective 2022.

  • Tennessee $76,652.43

     Earlier effective date granted for TDIU with special monthly compensation for housebound status.

  • Wisconsin $230,854.70

    Trauma and stressor-related disorder evaluated at 70% from 2013 and increased to 100%, effective 2024.

  • South Carolina $56,974.96

    Prostate cancer associated with TERA participation rated at 60% with special monthly compensation and related conditions, effective 2022.

  • Alabama $87,559.71

    Atrial fibrillation granted at 100% with eligibility for Dependents’ Educational Assistance, effective 2023.

  • Ohio $46,806.92

    PTSD with alcohol use disorder rated at 70%, effective 2023.

  • South Carolina $58,288.53

    Coronary artery disease and related cardiac conditions increased to 100% with special monthly compensation and Dependents’ Educational Assistance.

  • Texas $69,372.20

    Service connection granted for cervical spine conditions with bilateral radiculopathy, bilateral shoulder strain, multiple elbow and knee strains, and traumatic brain injury, effective 2024.

  • Wisconsin $131,750.16

    Bladder cancer granted at 100% for accrued purposes with service connection for cause of death.

  • Texas $79,055.74

    COPD and emphysema granted at 100% because of a CUE with special monthly compensation and Dependents’ Educational Assistance, effective 2022.

  • Illinois $155,806.24

    Oral neoplasm squamous cell carcinoma of the tongue increased from 0% to 100% with eligibility for Dependents’ Educational Assistance, effective 2022.

  • Georgia $48,976.04

    Adjustment disorder with mixed anxiety and depressed mood rated at 100% with eligibility for Dependents’ Educational Assistance, effective 2024.

  • Florida $51,717.33

    Earlier effective date granted for persistent depressive disorder with intermittent major depressive episodes, effective 2019.

  • California $30,952.94

    Service connection granted for lumbosacral strain, cervical spine strain, bilateral upper extremity radiculopathy, and bilateral plantar fasciitis, effective 2024.

  • Illinois $35,381.10

    Major depressive disorder with generalized anxiety at 70% and migraine and tension headaches at 30%, effective 2024, with eligibility for Dependents’ Educational Assistance.

  • Florida 129,376.81

    Earlier effective date approved for major depressive disorder, and tinnitus. A dependent added, all effective 2017.

  • Illinois 32,187.94

    Earlier effective date for bipolar disorder because of a CUE, therefore a 70% evaluation assigned, effective 2023.

  • Minnesota 56,936.98

    After identifying a clear VA error, we helped secure service connection and compensation that led to $56,936.98 in awarded benefits.

  • Oklahoma 115,409.48

    100% service connection granted for chronic kidney disease with end-stage renal disease.

  • Arizona 72,045.76

    100% service connection granted and multiple conditions approved, in addition to Dependents Educational Assistance eligibility secured.

  • California 59,099.58

    100% rating for coronary artery bypass graft, SMC for loss of use, additional ratings for skin cancer, ED, and scarring.